DUPONT CAPITAL MANAGEMENT CORP - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 52 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$1,025,000
+1.8%
100,0000.0%0.05%
+2.1%
Q4 2022$1,007,000
+2.1%
100,0000.0%0.05%
-18.6%
Q3 2022$986,000
+1.2%
100,0000.0%0.06%
+28.3%
Q2 2022$974,000
-0.2%
100,0000.0%0.05%
+17.9%
Q1 2022$976,0000.0%100,0000.0%0.04%
+11.4%
Q4 2021$976,000
-0.2%
100,0000.0%0.04%
+12.9%
Q3 2021$978,000100,0000.03%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q4 2022
NameSharesValueWeighting ↓
683 Capital Management, LLC 1,199,000$11,798,0000.91%
Atalaya Capital Management LP 500,000$4,930,0000.67%
MMCAP International Inc. SPC 800,000$7,872,0000.62%
ANGELO GORDON & CO., L.P. 300,000$2,952,0000.53%
Arena Capital Advisors, LLC- CA 141,317$1,393,0000.42%
DG Capital Management, LLC 94,629$933,0000.41%
KIM, LLC 800,000$7,888,0000.37%
FIR TREE CAPITAL MANAGEMENT LP 953,603$9,403,0000.32%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$4,928,0000.27%
Exos TFP Holdings LLC 43,165$425,0000.20%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders